approval
saveMYCOPHENOLATE MOFETIL — FDA approval
community read0 votes
Sponsor: AMNEAL. Form: FOR SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMYCOPHENOLATE MOFETIL — FDA approvalApr 10, 2026 · 173d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalMar 18, 2026 · 196d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalFeb 23, 2026 · 219d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 259d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 259d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalSep 26, 2024 · 734d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 778d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 778d ago
same company · ±60 days · 6
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalDec 21, 2022
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalDec 16, 2022
- approvalBREXPIPRAZOLE: BREXPIPRAZOLE — FDA approvalJan 31, 2023
- approvalVIGABATRIN — FDA approvalNov 8, 2022
- approvalVIGABATRIN — FDA approvalNov 8, 2022
- approvalVIGABATRIN — FDA approvalNov 8, 2022
comments(0)
5-min edit window · permanent after that